Quintiles Library

Featured Podcast

The Friday Podcast: Direct-to-Patient Registries
...
Show Filters
Press Release
SHANGHAI – 29 May 2015 – More than 30 leaders from China’s government and healthcare communities joined Quintiles executives here today in officially opening the Quintiles Greater China Regional Headquarters, further expanding its ability to help Chinese companies expand globally and multinational companies succeed in the world’s second largest biopharmaceutical market. The event comes 17 years after Quintiles first opened an office in Shanghai. “Today we celebrate not only Quintiles’ growth, but also Greater China’s emergence as a global player in biopharma R&D,” said Quintiles founder and Executive Chairman Dennis Gillings, CBE, Ph.D., at the opening ceremony at Shanghai’s Feng Lin Science Park. “Two decades ago we opened in Shanghai with 20 employees across Greater China – now we...
Read More
Fact Sheet
クインタイルズの拡大RBMソリューションであるDTE (Data-driven Trial Execution)...
Read More
Brochure
クインタイルズの拡大RBMソリューションであるDTE (Data-driven Trial Execution)...
Read More
White Paper
クインタイルズの拡大RBMソリューションであるDTE (Data-driven Trial...
Explore More
Case Study
Novel targeted drug therapies have transformed the way metastatic kidney cancer is treated. As patients live longer, there is an increasing demand on clinical services, leading to oncologists becoming stretched. A leading NHS Trust cancer center wanted to examine the core challenges they were facing, involving clinic waiting times and the duration of patient appointments, as well as the lack of available data and reporting on clinic activity. Read our case study to learn more about project set-up and how meaningful improvement strategies were implemented to improve patient...
Read More
Case Study
This case study focuses on one of the largest non-surgical cancer centers in the UK. The center offers radiotherapy, chemotherapy and specialized treatments to a population of more than 1.5 million. Limited capacity meant that a gynecology cancer clinic was unable to maintain its level of follow-up appointments. Alternative ways to deliver efficient and effective follow-up care for patients was needed, while also addressing waste, harm and variation. Read this case study to learn more about the set-up of the project and how a pathway redesign could help agree on new appropriate pathways for follow-up patients to improve their...
Read More
Fact Sheet
Quintiles’ approach to clinical trial development. For expert perspectives and insights on a fully integrated approach to clinical development to help your trials come in on-time and...
Read More
Video
Jeanne Hecht discusses the importance of early engagement with patient advocacy groups. ...
Video
Jeanne Hecht explains the benefits of working with prime and partner investigative sites. ...
Fact Sheet
Bringing a new therapy to market is a complex process and it becomes even more challenging in the area of oncology. With an expected increase in people diagnosed with cancer, the budget of the NHS in the UK will be challenged in the future. However, there are ways for pharmaceutical companies to get new innovative therapies to market while at the same support the NHS in managing their budget. Read our factsheet and learn how localized solutions could help you improve patient access to new treatments, improve care pathways and demonstrate the real value of your...
Read More
Video 04:00
In 2009, Lindsey Elsaesser gave birth to a baby girl, Evie. But even before Evie was born, her story was unlike most. She was born with a rare genetic condition called hypophosphatasia (HPP), which inhibits affects the growth of bones and teeth. Here, Lindsey shares how Evie’s participation in a clinical trial provided her with hope for a brighter, healthier future. This is the player to use for single videos on Q.com ...
White Paper
Immunotherapy – using small molecules and biologics that provide therapeutic benefit by focusing the capabilities of the immune system on the tumor – promises to transform cancer care, having already shown striking patient responses. This paper provides an overview of the clinical immunotherapy landscape and offers goals and cautions to inform the development of therapies that enlist the power of the immune system to attack lethal and resistant forms of cancer. Authors: Brad Smith, Ph.D., Vice President of Translational Medicine, Quintiles  Chris A. Learn, Ph.D., PMP, Senior Clinical Project Manager, Quintiles  Eric Groves, MD, Ph.D., Vice President, Center for Integrated Drug Development,...
Explore More
Fact Sheet
Biosimilars are highly similar- but more affordable- successors to biologic drugs whose patents have expired. Unlike generics, biosimilars are not exact copies of originators because the manufacturing process of these large, complex molecules is too difficult to replicate precisely. For this reason, biosimilars require comprehensive evaluation to gain regulatory...
Read More
Press Release
SINGAPORE – 25 May 2015 – To help Asia-Pacific emerging biopharmaceutical companies achieve their growth aspirations, Quintiles today launched a new solution set tailored to meet the needs of emerging companies in the world’s most diverse and dynamic healthcare market. “Asia-Pacific is poised to become the world’s next biopharma powerhouse, not least because of its growing number of emerging companies with promising pipelines,” said Senior Vice President Ross Horsburgh, M.D., Quintiles Head of Clinical Development, Asia-Pacific.  “These companies face formidable challenges as they look to expand into markets or therapeutic areas in which they may have limited or no experience.   “From start-ups to larger emerging players, our Asia-Pac solution is designed to improve their probability...
Read More
Fact Sheet
Selecting the right development partner is a balancing act. Do you want a local partner or one with access to extensive global resources? Broad or focused expertise? High touch or high tech? Low cost or high value? With the Quintiles Asia Pacific Emerging Biopharma Solution, you no longer have to compromise. Working on more than 60 studies for more than 45 Asia Pacific emerging biopharma customers since 2011, we’ve learned about your distinct challenges firsthand. And we’ve incorporated customer feedback to tailor a solution focused on your...
Read More
Podcast
Having just recognized International Clinical Trials Day, Jennifer Byrne from PMG Research discusses the numerous benefits of clinical trial...
Scientific Poster
Using simulation and data from a real-world trial we show that this effect is not trivial and complicates the interpretation of κ changes in the interpretation of reader performance, which, admittedly can change because of a multitude of...
Explore More
Video 02:44
Immunotherapy – using small molecules and biologics that provide therapeutic benefit by focusing the capabilities of the immune system on the tumor – promises to transform cancer care, having already shown striking patient responses. In this video, Phil Breitfeld, vice president and global head of the Quintiles Therapeutic Centers of Excellence, explores how immunotherapies could be used in real-world settings – alone or in combination with existing therapies – to improve cancer patients’ outcomes. This is the player to use for single videos on Q.com ...
Video 02:36
By 2025, we expect that sophisticated genomics-based tools will have transformed cancer care. In this video, Phil Breitfeld, vice president and global head of the Quintiles Therapeutic Centers of Excellence, discusses the history of genomics in oncology research and how this science is leading us to new ways of treating cancer. This is the player to use for single videos on Q.com ...
Video 03:36
Immunotherapy – using small molecules and biologics that provide therapeutic benefit by focusing the capabilities of the immune system on the tumor – promises to transform cancer care, having already shown striking patient responses. In this video, Phil Breitfeld, vice president and global head of the Quintiles Therapeutic Centers of Excellence, discusses some of the latest developments in immunotherapy for oncology. This is the player to use for single videos on Q.com ...